Cargando…

Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats

Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used to treat type 2 diabetes, reduce blood pressure (BP) in hypertensive patients. Whether this action involves central mechanisms is unknown. We here report that repeated lateral ventricular (LV) injection of GLP-1R agonist, liraglutide, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsurada, Kenichi, Nakata, Masanori, Saito, Toshinobu, Zhang, Boyang, Maejima, Yuko, Nandi, Shyam S., Sharma, Neeru M., Patel, Kaushik P., Kario, Kazuomi, Yada, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753091/ https://www.ncbi.nlm.nih.gov/pubmed/31537818 http://dx.doi.org/10.1038/s41598-019-49364-x

Ejemplares similares

TRPV1-Mediated Sensing of Sodium and Osmotic Pressure in POMC Neurons in the Arcuate Nucleus of the Hypothalamus
por: Zhang, Boyang, et al.
Publicado: (2022)

Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
por: Katsurada, Kenichi, et al.
Publicado: (2016)

Sympathetic modulation by antihypertensive drugs
por: Katsurada, Kenichi, et al.
Publicado: (2021)

Neurogenic Hypertension Mediated Mitochondrial Abnormality Leads to Cardiomyopathy: Contribution of UPR(mt) and Norepinephrine-miR- 18a-5p-HIF-1α Axis
por: Nandi, Shyam S., et al.
Publicado: (2021)

Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
por: Kario, Kazuomi
Publicado: (2019)

GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation
por: Katsurada, Kenichi, et al.
Publicado: (2020)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Systematic Morphometry of Catecholamine Nuclei in the Brainstem
por: Bucci, Domenico, et al.
Publicado: (2017)

Central Ang II (Angiotensin II)-Mediated Sympathoexcitation: Role for HIF-1α (Hypoxia-Inducible Factor-1α) Facilitated Glutamatergic Tone in the Paraventricular Nucleus of the Hypothalamus
por: Sharma, Neeru M., et al.
Publicado: (2020)

Management of Hypertension in the Digital Era: Small Wearable Monitoring Devices for Remote Blood Pressure Monitoring
por: Kario, Kazuomi
Publicado: (2020)

Digital Hypertension 2023: Concept, hypothesis, and new technology
por: Kario, Kazuomi, et al.
Publicado: (2022)

Update on Hypertension Research in 2021
por: Mogi, Masaki, et al.
Publicado: (2022)

Systolic hypertension: an increasing clinical challenge in Asia
por: Park, Jeong Bae, et al.
Publicado: (2015)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

Central insulin action induces activation of paraventricular oxytocin neurons to release oxytocin into circulation
por: Zhang, Boyang, et al.
Publicado: (2018)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy
por: Katsurada, Kenichi, et al.
Publicado: (2014)

Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis
por: Byrne, Collin J., et al.
Publicado: (2018)

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
por: Kario, Kazuomi, et al.
Publicado: (2022)

Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension
por: Jordan, Jens, et al.
Publicado: (2022)

Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension
por: Jordan, Jens, et al.
Publicado: (2022)

Progression from prehypertension to hypertension and risk of cardiovascular disease
por: Ishikawa, Yukiko, et al.
Publicado: (2016)

Brainstem Hypoxia Contributes to the Development of Hypertension in the Spontaneously Hypertensive Rat
por: Marina, Nephtali, et al.
Publicado: (2015)

The HOPE Asia Network activity 2022: Towards better hypertension management in Asia
por: Kario, Kazuomi, et al.
Publicado: (2022)

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation
por: Kario, Kazuomi, et al.
Publicado: (2023)

Hypertensive Encephalopathy with Reversible Brainstem Edema
por: Lee, Sungjoon, et al.
Publicado: (2013)

Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
por: Harding, Matthew, et al.
Publicado: (2021)

Medical Telemonitoring for the Management of Hypertension in Older Patients in Japan
por: Fujiwara, Takeshi, et al.
Publicado: (2023)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles
por: Narita, Keisuke, et al.
Publicado: (2022)

Corticosterone Upregulates Gene and Protein Expression of Catecholamine Markers in Organotypic Brainstem Cultures
por: Busceti, Carla L., et al.
Publicado: (2019)

Two Cases of Hypertensive Encephalopathy Involving the Brainstem
por: Kang, Sa-Yoon, et al.
Publicado: (2007)

Catecholamine Storage Vesicles: Role of Core Protein Genetic Polymorphisms in Hypertension
por: Zhang, Kuixing, et al.
Publicado: (2010)

PREDICTORS OF PLASMA AND URINARY CATECHOLAMINE LEVELS IN NORMOTENSIVE AND HYPERTENSIVE MEN AND WOMEN
por: Saxena, Aditi R., et al.
Publicado: (2013)

INVOLVEMENT OF CATECHOLAMINES IN THE MYOCARDIUM OF RATS SUBMITTED TO EXPERIMENTAL MODEL OF PORTAL HYPERTENSION
por: VINHOLI, Antonella, et al.
Publicado: (2018)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

High-Fat Diet Augments VPAC1 Receptor-Mediated PACAP Action on the Liver, Inducing LAR Expression and Insulin Resistance
por: Nakata, Masanori, et al.
Publicado: (2016)

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2014)

No Elevated Plasma Catecholamine Levels during Sleep in Newly Diagnosed, Untreated Hypertensives
por: Rasch, Björn, et al.
Publicado: (2011)

Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis
por: Zbroch, Edyta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_puellqpb0ej9p3a1u94mg2ck69